1
|
Dong Y, Hsiao Y, Dawson N, Banerji N, Nation K. The Emotional Content of Children's Writing: A Data-Driven Approach. Cogn Sci 2024; 48:e13423. [PMID: 38497526 DOI: 10.1111/cogs.13423] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/01/2023] [Revised: 01/29/2024] [Accepted: 02/16/2024] [Indexed: 03/19/2024]
Abstract
Emotion is closely associated with language, but we know very little about how children express emotion in their own writing. We used a large-scale, cross-sectional, and data-driven approach to investigate emotional expression via writing in children of different ages, and whether it varies for boys and girls. We first used a lexicon-based bag-of-words approach to identify emotional content in a large corpus of stories (N>100,000) written by 7- to 13-year-old children. Generalized Additive Models were then used to model changes in sentiment across age and gender. Two other machine learning approaches (BERT and TextBlob) validated and extended these analyses, converging on the finding that positive sentiments in children's writing decrease with age. These findings echo reports from previous studies showing a decrease in mood and an increased use of negative emotion words with age. We also found that stories by girls contained more positive sentiments than stories by boys. Our study shows the utility of large-scale data-driven approaches to reveal the content and nature of children's writing. Future experimental work should build on these observations to understand the likely complex relationships between written language and emotion, and how these change over development.
Collapse
Affiliation(s)
- Yuzhen Dong
- Department of Experimental Psychology, University of Oxford
| | | | - Nicola Dawson
- Department of Experimental Psychology, University of Oxford
| | | | - Kate Nation
- Department of Experimental Psychology, University of Oxford
| |
Collapse
|
2
|
Shah S, Jatar SS, Hsueh J, Gallagher L, Pepin A, Danner M, Zwart A, Ayoob MJ, Yung T, Kumar D, Aghdam N, Leger P, Dawson N, Suy S, Collins SP. Bothersome Hot Flashes Following Neoadjuvant Androgen Deprivation Therapy and Stereotactic Body Radiotherapy for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 2023; 117:e258-e259. [PMID: 37784992 DOI: 10.1016/j.ijrobp.2023.06.1210] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Androgen deprivation therapy (ADT) may improve cancer control in unfavorable localized prostate cancer treated with stereotactic body radiotherapy (SBRT). ADT is known to cause hormonally related symptoms that resolve with testosterone recovery. Hot flashes are particularly burdensome. This study sought to evaluate the timeline of hot flashes following short-course ADT and SBRT as well as its relationship with testosterone recovery. MATERIALS/METHODS Institutional IRB approval was obtained for this retrospective review of prospectively collected data (IRB#: 2009-510). ADT was initiated three months prior to the start of SBRT. Hot flashes were self-reported via question 13a a healthcare software prior to ADT initiation, the first day of robotic SBRT, and at each follow-up (1, 3, 6, 9, 12, 18, 24 and 36 months). The responses were grouped into three relevant categories (no problem, very small-small problem and moderate-big problem). Scores were transformed to a 0-100 scale with higher scores reflecting less bother. Testosterone levels were measured at each follow-up. RESULTS From 2007 to 2010, 122 localized prostate cancer patients (9 low-, 64 intermediate-, and 49 high-risk according to the D'Amico classification) at a median age of 72 years (range 54.5-88.3) were treated with short course ADT (3-6 months) and SBRT (35-36.25 Gy) at Georgetown University Hospital. Thirty-two percent were black and 27% were obese. 77% of patient received three months of ADT. At baseline, 2% of men experienced hot flashes that were a "moderate to big problem" and that proportion peaked at the start of SBRT (45%) before returning to baseline 9 months post-SBRT with a cumulative incidence of 52.4%. The median baseline healthcare software hot flash score of 94 declined to 50 at the start of SBRT but this returned to baseline by six months post SBRT. These changes were both statistically and clinically significant (MID = 9.5083). Testosterone recovery (> 230 ng/dL) occurred in approximately 70% of patients by 12 months post SBRT. Resolution of hot flashes correlated with testosterone recovery. CONCLUSION Bothersome hot flashes occur in greater than 50% of men treated with neoadjuvant ADT. Resolution of hot flashes occurs in the majority of patients within one year after treatment. Reassurance of the temporary nature of hot flashes may assist in reducing patient anxiety. Measuring testosterone levels at follow-up visits may allow for anticipatory counseling that may limit the associated bother.
Collapse
Affiliation(s)
- S Shah
- Department of Radiation Medicine, Georgetown University Hospital, Washington, DC
| | - S S Jatar
- Georgetown School Of Medicine, Washington, DC
| | - J Hsueh
- Department of Radiation Medicine, Georgetown University Hospital, Washington, DC
| | - L Gallagher
- Department of Radiation Medicine, Georgetown University Hospital, Washington, DC
| | - A Pepin
- Department of Radiation Oncology, Abramson Cancer Center, Hospital of University of Pennsylvania, Philadelphia, PA
| | - M Danner
- Department of Radiation Medicine, Georgetown University Hospital, Washington, DC
| | - A Zwart
- Department of Radiation Medicine, Georgetown University Hospital, Washington, DC
| | - M J Ayoob
- Department of Radiation Medicine, Georgetown University Hospital, Washington, DC
| | - T Yung
- Department of Radiation Medicine, Georgetown University Hospital, Washington, DC
| | - D Kumar
- Biotechnology Research Institute, North Carolina Central University, Durham, NC
| | - N Aghdam
- Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Washington, DC
| | - P Leger
- Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC
| | - N Dawson
- Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC
| | - S Suy
- Department of Radiation Medicine, MedStar Georgetown University Hospital, Washington, DC
| | - S P Collins
- Department of Radiation Medicine, MedStar Georgetown University Hospital, Washington, DC
| |
Collapse
|
3
|
Jatar SS, Shah S, Hsueh J, Gallagher L, Danner M, Zwart A, Ayoob MJ, Yung T, Kumar D, Leger P, Aghdam N, Dawson N, Suy S, Collins SP. Bothersome Gynecomastia Following Neoadjuvant GnRH Agonists and Stereotactic Body Radiotherapy for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys 2023; 117:e238-e239. [PMID: 37784943 DOI: 10.1016/j.ijrobp.2023.06.1163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/04/2023]
Abstract
PURPOSE/OBJECTIVE(S) Androgen deprivation therapy (ADT) is increasingly utilized in combination with stereotactic body radiotherapy (SBRT) for unfavorable prostate cancer. ADT such as gonadotropin releasing hormone (GnRH) agonists are known to cause hormonal-related side effects such as gynecomastia. The incidence of bothersome breast tenderness and/or enlargement following short course GnRH agonists and SBRT is unknown. This study sought to evaluate the timeline of gynecomastia as well as its relationship with testosterone recovery. MATERIALS/METHODS Gynecomastia was self-reported via question 13b of a healthcare software prior to ADT initiation, the first day of robotic SBRT, and at each follow-up (1, 3, 6, 9, 12, 18, 24 and 36 months). The responses were grouped into three relevant categories (no problem, very small-small problem, and moderate-big problem). Scores were transformed to a 0-100 scale with higher scores reflecting less bother. Testosterone levels were measured at each follow-up. RESULTS From 2007 to 2010, 122 localized prostate cancer patients (9 low-, 64 intermediate-, and 49 high-risk according to the D'Amico classification) at a median age of 72 years (range 54.5-88.3) were treated with short course ADT (3-6 months) and SBRT (35-36.25 Gy) at Georgetown University Hospital. Of the participants, 48% percent were non-white and 48% were overweight. 77% of patients received three months of ADT. At baseline, 2% of men experienced gynecomastia that was a "moderate to big problem" and that proportion peaked at 3 and 12 months post-SBRT (7%) before returning to less than baseline (0%) 24 months post-SBRT with a cumulative incidence of 14.75%. The median baseline healthcare software hot flash score of 98 declined to 90 at 3 months post-SBRT but this returned to baseline by 24 months post SBRT. These changes were both statistically and clinically significant (MID = 6.5). Testosterone recovery (> 230 ng/dL) occurred in approximately 70% of patients by 12 months post SBRT. The development and resolution of gynecomastia fluctuated at various timepoints and did not directly correlate with testosterone recovery. CONCLUSION Bothersome gynecomastia occurs in less than 15% of men treated with neoadjuvant ADT. Resolution of gynecomastia occurs in most patients within two years after treatment. Reassurance of the temporary nature of gynecomastia may assist in reducing patient anxiety. Institutional IRB (IRB#: 2009-510) approval was obtained for retrospective review of prospectively collected data.
Collapse
Affiliation(s)
- S S Jatar
- Georgetown School Of Medicine, Washington, DC
| | - S Shah
- Department of Radiation Medicine, Georgetown University Hospital, Washington, DC
| | - J Hsueh
- Department of Radiation Medicine, Georgetown University Hospital, Washington, DC
| | - L Gallagher
- Department of Radiation Medicine, Georgetown University Hospital, Washington, DC
| | - M Danner
- Department of Radiation Medicine, Georgetown University Hospital, Washington, DC
| | - A Zwart
- Department of Radiation Medicine, Georgetown University Hospital, Washington, DC
| | - M J Ayoob
- Department of Radiation Medicine, Georgetown University Hospital, Washington, DC
| | - T Yung
- Department of Radiation Medicine, Georgetown University Hospital, Washington, DC
| | - D Kumar
- Biotechnology Research Institute, North Carolina Central University, Durham, NC
| | - P Leger
- Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC
| | - N Aghdam
- Department of Radiation Oncology, Beth Israel Deaconess Medical Center, Washington, DC
| | - N Dawson
- Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC
| | - S Suy
- Department of Radiation Medicine, MedStar Georgetown University Hospital, Washington, DC
| | - S P Collins
- Department of Radiation Medicine, MedStar Georgetown University Hospital, Washington, DC
| |
Collapse
|
4
|
Dawson N, Chunga E. Reflective supervision: The symbolic hands that hold. Psychol Serv 2023; 20:300-305. [PMID: 36757957 DOI: 10.1037/ser0000741] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/10/2023]
Abstract
Nonprofit organizations, providing psychotherapy services in community-based settings, are often faced with the tensions inherent in both ensuring quality services while limiting program costs. The same is true in private and public health care settings, where services regularly navigate cost reductions and budget cuts. At the Ububele Educational and Psychotherapy Trust, an nonprofit organization in South Africa, reflective supervision is seen as a critical component for effective, ethically sound, and culturally sensitive intervention despite competition for financial resources. This article will provide an overview of the organization's reflective supervision model, motivating for the need to prioritize reflective supervision for frontline staff. It also provides a case example, to demonstrate the value of reflective supervision for promoting practitioner reflexivity and preventing practitioner burnout in a highly traumatized environment. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
Collapse
|
5
|
Dawson N, Bain K. What watching others watching can tell us: using video vignettes alongside narrative interviews to access multiple positions and embodied information in cross-cultural mother-infant research. Qualitative Research in Psychology 2021. [DOI: 10.1080/14780887.2021.1966559] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- Nicola Dawson
- Department of Psychology, University of Witwatersrand, Johannesburg, South Africa
- Ububele Educational & Psychotherapy Trust, Sandton, South Africa
| | - Katherine Bain
- Department of Psychology, University of Witwatersrand, Johannesburg, South Africa
| |
Collapse
|
6
|
Dawson N, Rastle K, Ricketts J. Finding the man amongst many: A developmental perspective on mechanisms of morphological decomposition. Cognition 2021; 211:104605. [PMID: 33621738 DOI: 10.1016/j.cognition.2021.104605] [Citation(s) in RCA: 9] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/27/2018] [Revised: 01/10/2021] [Accepted: 01/13/2021] [Indexed: 11/30/2022]
Abstract
Skilled reading is characterized by rapid recognition of morphologically complex words. Evidence suggests that adult readers segment complex words into their constituent morphemes during visual word recognition, and that this extends to items that have only a surface morphological structure (e.g., corner), a process termed 'morpho-orthographic segmentation'. It is not yet known how and when this mechanism is established over the course of reading development, although data from English-speaking children suggest that it may be a relatively late-acquired milestone. The purpose of this study was to examine for the first time the mechanisms driving morphological processing across late childhood and adolescence. A cross-sectional sample of 204 children and adolescents from South-East England, ranging in age from 9 to 18 years (M age = 13.74 years, SD = 2.68; 110 female), completed a visual masked prime lexical decision task using three sets of prime-target pairs: morphological (e.g., teacher - TEACH), pseudomorphological (sharing an apparent morphological relationship in the absence of a semantic relationship, e.g., corner - CORN), and form (sharing an orthographic relationship only, e.g., window - WIND). Linear mixed effects models revealed both morphological and pseudomorphological priming in the absence of form priming, with priming magnitude increasing in line with age, and stronger evidence of morpho-orthographic segmentation emerging in line with word reading efficiency. Our findings reveal advances in the reading system during adolescence which may reflect accumulated exposure to regularities in the writing system, facilitating rapid access to meaning from print.
Collapse
Affiliation(s)
- Nicola Dawson
- Royal Holloway, University of London, United Kingdom.
| | | | | |
Collapse
|
7
|
Dawson N, Bain K, Mesman J. Observing maternal sensitivity in a South African township: an exploratory study into behavioral features using different measures. Attach Hum Dev 2020; 23:150-163. [PMID: 33016856 DOI: 10.1080/14616734.2020.1828531] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
Abstract
There is evidence that sensitive responsiveness is manifested differently in varying cultural contexts. This exploratory study examines a sample of 50 South African mothers in the context of a socioeconomically deprived Township, and investigates differences between the Ainsworth sensitivity scale (that does not specify particular manifestations of sensitivity) and the Maternal Behavior Q-sort (MBQ) mini, that assesses a more specified array of behaviors. Results showed a significant but modest association between the two measures, and maternal education was related to the MBQ-mini but not the Ainsworth scores. This pattern of results appears to be due to the higher salience of social games and verbal teaching in the MBQ-mini than in the Ainsworth scale. Such behaviors are less common in South African parenting, where more physical forms of responsiveness seem more typical. A local "South African" sort was developed to capture culture-specific manifestations of sensitivity.
Collapse
Affiliation(s)
- Nicola Dawson
- School of Human and Community Development, University of Witwatersrand, Johannesburg, South Africa.,Ububele Educational and Psychotherapy Trust, Johannesburg, South Africa
| | - Katherine Bain
- School of Human and Community Development, University of Witwatersrand, Johannesburg, South Africa
| | - Judi Mesman
- Institute of Education and Child Studies, Leiden University, Leiden, The Netherlands
| |
Collapse
|
8
|
Dawson N, Atkins D, Chizmar S, Manoogian D, Gabriel M. THE RELATIONSHIP BETWEEN PHYSICIAN SPECIALTY AND TREATMENT MODALITY FOR OSTEOARTHRITIS IN WOMEN 65+. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.553] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
9
|
Gunzler D, Perzynski A, Liu J, Dawson N, NEOCARE T, Dalton J. INTRODUCING A RISK-PERIOD-COHORT APPROACH FOR ADDRESSING IDENTIFICATION PROBLEMS IN AGE-PERIOD-COHORT ANALYSES. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.3201] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
| | - A Perzynski
- MetroHealth Medical Center and Case Western Reserve University
| | - J Liu
- Case Western Reserve University
| | | | - T NEOCARE
- Northeast Ohio Cohort for Atherosclerotic Risk Estimation (NEOCARE) Learning Health Registry Project
| | - J Dalton
- Cleveland Clinic Lerner College of Medicine and CWRU
| |
Collapse
|
10
|
Dalton J, Rothberg M, Dawson N, Zidar D, Gunzler D, NEOCARE T, Perzynski A. ACCURACY OF CARDIOVASCULAR RISK ASSESSMENT MODELS ACROSS THE LIFE COURSE. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.3184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Affiliation(s)
- J Dalton
- Cleveland Clinic Lerner College of Medicine and CWRU
| | | | | | | | | | - T NEOCARE
- Northeast Ohio Cohort for Atherosclerotic Risk Estimation (NEOCARE) Learning Health Registry Project
| | - A Perzynski
- MetroHealth Medical Center and Case Western Reserve University
| |
Collapse
|
11
|
Dawson N, Judge K, Trapuzzano A. IMPACT OF THE LEVERAGING EXISTING ABILITIES IN DEMENTIA (LEAD) TRAINING PROGRAM ON CONFIDENCE AND PRACTICE PATTERNS. Innov Aging 2018. [DOI: 10.1093/geroni/igy023.480] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
12
|
Abstract
Recent scholarly insights show that nonverbal and subtle forms of sensitive responsiveness are more applicable to describing and assessing non-Western parent-infant interactions than the more extraverted Western varieties of responsiveness. This paper examines whether the original Ainsworth scale (that does not specify particular manifestations of sensitivity) reveals different patterns of results in 50 South African mothers when compared to the Maternal Behavior Q-sort mini that assesses a more specified array of behaviors that may vary in their goodness of fit regarding the cultural context. The analysis reveals that there are key differences in the way the two measures operationalize maternal sensitivity, as seen in the incongruence of sensitivity ratings. The two measures are also shown to relate differently to maternal education and reflective functioning in this sample. The paper concludes that the Ainsworth sensitivity scale is better suited for use in the context of Alexandra Township, Johannesburg.
Collapse
Affiliation(s)
- Nicola Dawson
- a School of Human and Community Development , University of Witwatersrand , Johannesburg , South Africa
- b Ububele Educational and Psychotherapy Trust , Johannesburg , South Africa
| | - Katherine Bain
- a School of Human and Community Development , University of Witwatersrand , Johannesburg , South Africa
| | - Judi Mesman
- c Centre for Child and Family Studies , Leiden University , Netherlands
| |
Collapse
|
13
|
Kahn M, Dawson N, Evenson N, Unsworth A, Campbell N. 86Incorrect coding of atrial fibrillation leads to under-treatment with anticoagulation in pacing clinics. Europace 2017. [DOI: 10.1093/europace/eux283.081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
14
|
Abstract
The process by which morphologically complex words are recognized and stored is a matter of ongoing debate. A large body of evidence indicates that complex words are automatically decomposed during visual word recognition in adult readers. Research with developing readers is limited and findings are mixed. This study aimed to investigate morphological decomposition in visual word recognition using cross-sectional data. Participants (33 adults, 36 older adolescents [16 to 17 years], 37 younger adolescents [12 to 13 years], and 50 children [7 to 9 years]) completed a timed lexical-decision task comprising 120 items (60 nonwords and 60 real word fillers). Half the nonwords contained a real stem combined with a real suffix (pseudomorphemic nonwords, e.g., earist); the other half used the same stems combined with a nonmorphological ending (control nonwords, e.g., earilt). All age groups were less accurate in rejecting pseudomorphemic nonwords than control nonwords. Adults and older adolescents were also slower to reject pseudomorphemic nonwords compared with control nonwords, but this effect did not emerge for the younger age groups. These findings demonstrate that, like adults, children and adolescents are sensitive to morphological structure in online visual word processing, but that some important changes occur over the course of adolescence.
Collapse
|
15
|
Rescigno P, de Bono J, Aparicio A, Chowdhury S, Twardowski P, Dawson N, Vaishampayan U, Pantuck A, Zhou Y, Fecteau D, Ganji G, Tolson J, Smith D, Medina J, Yan L. Phase I, open-label, dose-finding study of GSK2636771, a phosphoinositide 3-kinase (PI3K)β inhibitor, in combination with enzalutamide in male subjects with metastatic castration-resistant prostate cancer (mCRPC). Ann Oncol 2017. [DOI: 10.1093/annonc/mdx370.009] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
16
|
Allison E, Dawson N, Phillips J, Lynch C, Coleman J. Fifteen minute consultation: A structured approach to the management of children and adolescents with medically unstable anorexia nervosa. Arch Dis Child Educ Pract Ed 2017; 102:175-181. [PMID: 28193620 DOI: 10.1136/archdischild-2016-311394] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/31/2016] [Revised: 12/01/2016] [Accepted: 01/11/2017] [Indexed: 11/04/2022]
Abstract
Assessing and managing children who are underweight is an integral part of paediatric practice. Young people with anorexia nervosa (AN) are mainly cared for in the community by specialist eating disorder services. However, increasing numbers require admission to paediatric wards with medical instability due to the complications of starvation. Despite recommendations published in the junior MARSIPAN report in 2012, many paediatricians still feel poorly equipped to care for these high-risk patients. This article aims to provide a safe and structured approach to the assessment and management of children and adolescents with medically unstable AN.
Collapse
Affiliation(s)
- Elizabeth Allison
- Department of Paediatrics, Airedale NHS foundation trust, Steeton, UK
| | - Nicola Dawson
- Community Eating Disorder Service for Children and Young People, Hillbrook Child and Adolescent Mental Health Service, Keighley, UK
| | - Jane Phillips
- Department of Paediatrics, Airedale NHS foundation trust, Steeton, UK
| | | | | |
Collapse
|
17
|
Dawson N, Judge K, Gregory M. RESULTS OF A MODERATE-INTENSITY EXERCISE PROGRAM FOR IWDS: IMPLICATIONS AND FUTURE DIRECTIONS. Innov Aging 2017. [DOI: 10.1093/geroni/igx004.660] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- N. Dawson
- University of Central Florida, Orlando, Florida,
| | - K.S. Judge
- Cleveland State University, Cleveland, Ohio
| | - M. Gregory
- University of Central Florida, Orlando, Florida,
| |
Collapse
|
18
|
Kahn MB, Unsworth A, Evenson N, Dawson N, Hopkins A, Campbell NG. P1447Incorrect coding of atrial fibrillation leads to under-treatment with anticoagulation in pacing clinics. Europace 2017. [DOI: 10.1093/ehjci/eux158.074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
19
|
Dawson N, Richards J, Frost K. The Ububele Baby Mat Service – A primary preventative mental health intervention in a culturally diverse setting. J Child Adolesc Ment Health 2017; 29:85-97. [DOI: 10.2989/17280583.2017.1297308] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- N Dawson
- The Ububele Educational and Psychotherapy Trust, Kew, Johannesburg, South Africa
| | - J Richards
- The Ububele Educational and Psychotherapy Trust, Kew, Johannesburg, South Africa
| | - K Frost
- The Ububele Educational and Psychotherapy Trust, Kew, Johannesburg, South Africa
| |
Collapse
|
20
|
Dang A, Hegde J, Dawson N, Dvorak R, Hoyt A, Hurvitz S, Kusske A, Silver E, Tseng C, McCloskey S. Multidisciplinary Breast Clinic: Impact on Pretreatment Evaluation, Timeliness, and Guideline Concordant Care. Int J Radiat Oncol Biol Phys 2016. [DOI: 10.1016/j.ijrobp.2016.06.623] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
21
|
Sinclair K, Sakellariou S, Dawson N, Litherland J. Does preoperative breast MRI significantly impact on initial surgical procedure and re-operation rates in patients with screen-detected invasive lobular carcinoma? Clin Radiol 2016; 71:543-50. [DOI: 10.1016/j.crad.2016.03.011] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/04/2015] [Revised: 03/10/2016] [Accepted: 03/15/2016] [Indexed: 11/30/2022]
|
22
|
Foley NM, Racz JM, Al-Hilli Z, Livingstone V, Cil T, Holloway CMB, Romics L, Matrai Z, Bennett MW, Duddy L, Nofech-Mozes S, Slodkowska E, Mallon EA, Dawson N, Roche T, Relihan N, Hill ADK, Redmond HP, Corrigan MA. An International Multicenter Review of the Malignancy Rate of Excised Papillomatous Breast Lesions. Ann Surg Oncol 2015; 22 Suppl 3:S385-90. [PMID: 26240010 DOI: 10.1245/s10434-015-4773-z] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/25/2015] [Indexed: 11/18/2022]
Abstract
BACKGROUND Papillary lesions of the breast are a relatively rare, but heterogeneous group ranging from benign to atypical and malignant. Debate exists regarding the optimal management of these lesions. In the absence of more accurate risk-stratification models, traditional management guidelines recommend surgical excision, despite the majority of lesions proving benign. This study sought to determine the rate of malignancy in excised breast papillomas and to elucidate whether there exists a population in which surgical excision may be unnecessary. METHODS A multicenter international retrospective review of core biopsy diagnosed breast papillomas and papillary lesions was performed between 2009 and 2013, following institutional ethical approval. Patient demographics, histopathological, and radiological findings were recorded. All data was tabulated, and statistical analysis performed using Stata. RESULTS A total of 238 patients were included in the final analysis. The age profile of those with benign pathology was significantly younger than those with malignant pathology (p < 0.001). Atypia on core needle biopsy was significantly associated with a final pathological diagnosis of malignancy (OR = 2.73). The upgrade rate from benign core needle biopsy to malignancy on the final pathological sample was 14.4 %; however, only 3.7 % had invasive cancer. CONCLUSIONS This international dataset is one of the largest in the published literature relating to breast papillomas. The overall risk of malignancy is significantly associated with older age and the presence of atypia on core needle biopsy. It may be possible to stratify higher-risk patients according to age and core needle biopsy findings, thereby avoiding surgery on low-risk patients.
Collapse
Affiliation(s)
- N M Foley
- Breast Research Centre, Cork University Hospital, Cork, Ireland.
| | - J M Racz
- Department of Surgical Oncology, University of Toronto, Toronto, ON, Canada
| | - Z Al-Hilli
- Department of Surgery, Beaumont Hospital, Dublin, Ireland.,The Royal College of Surgeons in Ireland, Dublin, Ireland
| | - V Livingstone
- Breast Research Centre, Cork University Hospital, Cork, Ireland
| | - T Cil
- Department of Surgical Oncology, University of Toronto, Toronto, ON, Canada
| | - C M B Holloway
- Department of Surgical Oncology, University of Toronto, Toronto, ON, Canada
| | - L Romics
- Departments of Breast Surgery, Radiology & Pathology, Victoria Infirmary, Glasgow, UK
| | - Z Matrai
- Department of Breast and Sarcoma Surgery, National Institute of Oncology, Budapest, Hungary
| | - M W Bennett
- Breast Research Centre, Cork University Hospital, Cork, Ireland
| | - L Duddy
- Breast Research Centre, Cork University Hospital, Cork, Ireland
| | - S Nofech-Mozes
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
| | - E Slodkowska
- Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
| | - E A Mallon
- Departments of Breast Surgery, Radiology & Pathology, Victoria Infirmary, Glasgow, UK
| | - N Dawson
- Departments of Breast Surgery, Radiology & Pathology, Victoria Infirmary, Glasgow, UK
| | - T Roche
- Department of Surgery, Beaumont Hospital, Dublin, Ireland.,The Royal College of Surgeons in Ireland, Dublin, Ireland
| | - N Relihan
- Breast Research Centre, Cork University Hospital, Cork, Ireland
| | - A D K Hill
- Department of Surgery, Beaumont Hospital, Dublin, Ireland.,The Royal College of Surgeons in Ireland, Dublin, Ireland
| | - H P Redmond
- Breast Research Centre, Cork University Hospital, Cork, Ireland
| | - M A Corrigan
- Breast Research Centre, Cork University Hospital, Cork, Ireland
| |
Collapse
|
23
|
Leigh S, Ping Lee Y, Whittall R, Dawson N, Das S, Martin A, Orengo C, Humphries S. Update and analysis of the ucl pro-protein convertase subtilisin / kexin type9 gene (pcsk9) variant database. Atherosclerosis 2014. [DOI: 10.1016/j.atherosclerosis.2014.05.262] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
24
|
Peiris L, Laws S, Dawson N, Rainsbury D. 26. The effect of the timing of radiotherapy on clinical and patient reported outcomes after breast reconstruction: a 10 year study. European Journal of Surgical Oncology 2014. [DOI: 10.1016/j.ejso.2014.02.216] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022]
|
25
|
Corman J, Dawson N, Hall S, Nabhan C, Ferrari A, Armstrong A, Murdock M, Stewart F, Sheikh N, Petrylak D. Openact: Phase 2, Open-Label Study of Sipuleucel-T in Metastatic Castrate-Resistant Prostate Cancer (MCRPC). Ann Oncol 2012. [DOI: 10.1016/s0923-7534(20)33504-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
26
|
Petrvlak D, Corman J, Hall S, Nabhan C, Ferrari A, Armstrong A, Dawson N, Sims R, Stewart F, Sheikh N. 7011 POSTER DISCUSSION Cellular and Humoral Immune System Activation by Sipuleucel-T -Preliminary Data From the OpenACT Phase 2 Trial. Eur J Cancer 2011. [DOI: 10.1016/s0959-8049(11)71962-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
27
|
Petrylak D, Corman J, Hall S, Nabhan C, Ferrari A, Armstrong A, Dawson N, Sims R, Stewart F, Sheikh N. MP-16.01 Cellular and Humoral Immune System Activation by Sipuleucel-T: Preliminary Data from the OpenACT Phase 2 Trial. Urology 2011. [DOI: 10.1016/j.urology.2011.07.369] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
28
|
Kwok Y, Wu Y, Mirmiran A, DiBiase S, Goloubeva O, Bridges B, Mannuel H, Dawson N, Amin P, Hussain A. Prospective Trial of Escalating Doses of Paclitaxel, Concurrent Radiation and Androgen Deprivation in High-risk Prostate Cancer with or without Prior Prostatectomy. Int J Radiat Oncol Biol Phys 2010. [DOI: 10.1016/j.ijrobp.2010.07.839] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
29
|
Glode LM, Tangen CM, Hussain MH, Wood DP, Swanson GP, Quinn DI, Dawson N, Balzer-Haas N, Crawford ED, Thompson IM. Southwest Oncology Group S9921: Prolonged event-free survival in high-risk prostate cancer (PC) patients receiving adjuvant androgen deprivation. J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.5009] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
5009 Background: Patients with adverse pathologic risk factors after radical prostatectomy are at high risk for biochemical relapse and eventual death from disease. Adjuvant hormonal therapy with or without chemotherapy may prolong event free survival. Methods: SWOG 9921 randomized 859 eligible high risk PC patients to receive 2 years of adjuvant combined androgen blockade (CAB) (goserelin + bicalutamide) with (433) or without (426) chemotherapy (mitoxantrone + prednisone). The primary endpoint is survival. The DSMC has approved this analysis. PSA was to be assessed every 3 mo for 5 yrs and then every 6 mo for 10 more yrs. PSA relapse was defined as 3 consecutive measurements > 0.2 ng/ml. Death w/o relapse is censored. The CAB only eligible group is being reported (n=426). Risk groups based on eligibility criteria are as follows: Risk Group 1= positive margins or extraprostatic extension only with Gleason 7; elevated PSA (pre-op > 15 ng/ml), or had a pre-op PSA > 10 ng/ml and a biopsy Gleason 7(N=113); Risk Group 2 = seminal vesicle invasion or Gleason >/= 8, but no positive nodes (N=240), Risk Group 3 =positive nodes (N=69), 397 patients from both arms who completed 2 years of CAB were assessed for time to testosterone (T) recovery. T was assessed every 6 mo until it reached the institutional lower limit of normal. The median follow-up time from randomization is 3.8 years. Results: See Table . The estimated median time to T recovery (> 50ng/ml) is 11.7 mo from the end of CAB (95% CI 11.3, 11.9 months). The 6 and 18 mo recovery rates were 16% and 89%. Of 17 deaths (including ineligibles), 7 were from prostate cancer; 4 from other cancers, one cardiovascular disease, and 5 from miscellaneous causes. Conclusions: These data indicate a markedly low PSA relapse and death rates in high risk PC patients who received CAB. This likely is the result of stage migration, patient selection and/or the effects of CAB itself. [Table: see text] [Table: see text]
Collapse
Affiliation(s)
- L. M. Glode
- University of Colorado Health Sciences Center, Aurora, CO; Southwest Oncology Group, Seattle, WA; University of Michigan, Ann Arbor, MI; University of Texas Health Sciences Center, San Antonio, TX; University of Southern California, Los Angeles, CA; University of Maryland & CALGB, Baltimore, MD; Fox Chase Cancer Center & ECOG, Philadelphia, PA
| | - C. M. Tangen
- University of Colorado Health Sciences Center, Aurora, CO; Southwest Oncology Group, Seattle, WA; University of Michigan, Ann Arbor, MI; University of Texas Health Sciences Center, San Antonio, TX; University of Southern California, Los Angeles, CA; University of Maryland & CALGB, Baltimore, MD; Fox Chase Cancer Center & ECOG, Philadelphia, PA
| | - M. H. Hussain
- University of Colorado Health Sciences Center, Aurora, CO; Southwest Oncology Group, Seattle, WA; University of Michigan, Ann Arbor, MI; University of Texas Health Sciences Center, San Antonio, TX; University of Southern California, Los Angeles, CA; University of Maryland & CALGB, Baltimore, MD; Fox Chase Cancer Center & ECOG, Philadelphia, PA
| | - D. P. Wood
- University of Colorado Health Sciences Center, Aurora, CO; Southwest Oncology Group, Seattle, WA; University of Michigan, Ann Arbor, MI; University of Texas Health Sciences Center, San Antonio, TX; University of Southern California, Los Angeles, CA; University of Maryland & CALGB, Baltimore, MD; Fox Chase Cancer Center & ECOG, Philadelphia, PA
| | - G. P. Swanson
- University of Colorado Health Sciences Center, Aurora, CO; Southwest Oncology Group, Seattle, WA; University of Michigan, Ann Arbor, MI; University of Texas Health Sciences Center, San Antonio, TX; University of Southern California, Los Angeles, CA; University of Maryland & CALGB, Baltimore, MD; Fox Chase Cancer Center & ECOG, Philadelphia, PA
| | - D. I. Quinn
- University of Colorado Health Sciences Center, Aurora, CO; Southwest Oncology Group, Seattle, WA; University of Michigan, Ann Arbor, MI; University of Texas Health Sciences Center, San Antonio, TX; University of Southern California, Los Angeles, CA; University of Maryland & CALGB, Baltimore, MD; Fox Chase Cancer Center & ECOG, Philadelphia, PA
| | - N. Dawson
- University of Colorado Health Sciences Center, Aurora, CO; Southwest Oncology Group, Seattle, WA; University of Michigan, Ann Arbor, MI; University of Texas Health Sciences Center, San Antonio, TX; University of Southern California, Los Angeles, CA; University of Maryland & CALGB, Baltimore, MD; Fox Chase Cancer Center & ECOG, Philadelphia, PA
| | - N. Balzer-Haas
- University of Colorado Health Sciences Center, Aurora, CO; Southwest Oncology Group, Seattle, WA; University of Michigan, Ann Arbor, MI; University of Texas Health Sciences Center, San Antonio, TX; University of Southern California, Los Angeles, CA; University of Maryland & CALGB, Baltimore, MD; Fox Chase Cancer Center & ECOG, Philadelphia, PA
| | - E. D. Crawford
- University of Colorado Health Sciences Center, Aurora, CO; Southwest Oncology Group, Seattle, WA; University of Michigan, Ann Arbor, MI; University of Texas Health Sciences Center, San Antonio, TX; University of Southern California, Los Angeles, CA; University of Maryland & CALGB, Baltimore, MD; Fox Chase Cancer Center & ECOG, Philadelphia, PA
| | - I. M. Thompson
- University of Colorado Health Sciences Center, Aurora, CO; Southwest Oncology Group, Seattle, WA; University of Michigan, Ann Arbor, MI; University of Texas Health Sciences Center, San Antonio, TX; University of Southern California, Los Angeles, CA; University of Maryland & CALGB, Baltimore, MD; Fox Chase Cancer Center & ECOG, Philadelphia, PA
| |
Collapse
|
30
|
Wu Y, Kwok Y, Mirmiran A, Goloubeva O, Mannuel H, Dawson N, Amin P, Hussain A. Weekly paclitaxel (P) with concurrent external beam radiation (EBRT) and androgen deprivation therapy (ADT) in high-risk prostate cancer (PC) patients with or without prior prostatectomy (RP). J Clin Oncol 2009. [DOI: 10.1200/jco.2009.27.15_suppl.5122] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
5122 Background: EBRT with ADT (4 mos to 2–3 yrs) is standard treatment for high risk PC. In this trial, we evaluated weekly P given concurrently with EBRT and ADT in high risk PC. Methods: For pts undergoing RP, high risk was defined as: pT3 and/or pN+, M0, and/or rising PSA (> 0.5) post RP. For pts not undergoing RP (i.e. locally advanced PC [LAPC]) high risk included: cT2b-4N0, N+, M0; bGS 8–10; bGS ≥ 7 + PSA ≥ 10 but ≤ 150; and/or PSA ≥ 20 but ≤ 150. Treatment included ADT (4 or 24 mos, preplanned based on clinical presentation), P (40, 50, or 60 mg/m2/wk) x 7 with EBRT, and whole pelvis EBRT 45 Gy with 19.8 Gy boost (total 64.8 Gy) to prostate bed in RP pts and 25.2 Gy boost (total 70.2 Gy) to prostate in LAPC pts. Results: Between October 1999 and December 2006, 59 pts (29 W, 28 AA) were enrolled (n = 29 LAPC, n = 30 RP); median age 67 yrs, median PSA at trial entry 5.9 (27.5 LAPC, 1.6 RP), median GS 8. Pts were enrolled at different weekly doses of P: 40 mg/m2 n = 10 pts; 50 mg/m2 n = 31 pts; 60 mg/m2 n = 18 pts. ADT for 4 mos was given in 29 pts and for 24 mos in 30 pts. At 40 mg/m2 67/70 (96%), 50 mg/m2 202/217 (93%), and 60 mg/m2 98/126 (78%) planned doses of P were given. There were no acute grade 4 toxicities. Most common grade 3 toxicities were diarrhea 15%, urinary urgency or incontinence 10%, tenesmus 5%, and leukopenia 3%. Median duration of f/u was 75.3 mos, OS 78%, biochemical progression 24/59 (41%) pts, clinical progression 11/59 (19%) pts. Time to biochemical progression was similar between RP vs. LAPC (p = 0.17), between ADT 4 mos vs. 24 mos (p = 0.61), and between AA vs. W (p = 0.54). Conclusions: This trial establishes the feasibility of tri-modality therapy with ADT, EBRT and weekly paclitaxel in high risk PC, both in RP pts and in LAPC pts with intact prostate glands. The maximum tolerated dose of paclitaxel is 50 mg/m2 /wk when given weekly with concurrent radiation to the pelvis and hormone ablation. No significant financial relationships to disclose.
Collapse
Affiliation(s)
- Y. Wu
- University of Maryland, Baltimore, MD; Georgetown University Medical Center, Washington, DC
| | - Y. Kwok
- University of Maryland, Baltimore, MD; Georgetown University Medical Center, Washington, DC
| | - A. Mirmiran
- University of Maryland, Baltimore, MD; Georgetown University Medical Center, Washington, DC
| | - O. Goloubeva
- University of Maryland, Baltimore, MD; Georgetown University Medical Center, Washington, DC
| | - H. Mannuel
- University of Maryland, Baltimore, MD; Georgetown University Medical Center, Washington, DC
| | - N. Dawson
- University of Maryland, Baltimore, MD; Georgetown University Medical Center, Washington, DC
| | - P. Amin
- University of Maryland, Baltimore, MD; Georgetown University Medical Center, Washington, DC
| | - A. Hussain
- University of Maryland, Baltimore, MD; Georgetown University Medical Center, Washington, DC
| |
Collapse
|
31
|
Kwok Y, Kataria R, Amin P, Naslund M, Hussain A, Dawson N, DiBiase S. Long-term Results of a Prospective Phase II Trial of Androgen Ablation, Pelvic External Beam Radiation Therapy, Brachytherapy Boost, and Adjuvant Docetaxel in High-risk Prostate Cancer. Int J Radiat Oncol Biol Phys 2008. [DOI: 10.1016/j.ijrobp.2008.06.935] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
32
|
Mannuel HD, Dawson N, Khan I, Feldman M, Boyle L, Besche M, Smoot J, Engstrom C, Monroe M, Hussain A. Initial results of ongoing phase I/II studies of weekly doxorubicin (Doxo)/docetaxel (Doce) in men with hormone refractory (HRPC) and hormone sensitive prostate cancer (HSPC). J Clin Oncol 2005. [DOI: 10.1200/jco.2005.23.16_suppl.4665] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | | | - I. Khan
- Univ of Maryland, Baltimore, MD
| | | | | | | | | | | | | | | |
Collapse
|
33
|
Dibiase SJ, Dawson N, Naslund M, Hussain A, Kataria R, Bangalore M, Dhople A, Guo C, Amin P. Phase II study of combined external beam radiation therapy (EBRT), brachytherapy (PB), total androgen suppression (TAS), and adjuvant docetaxel (AD) in poor-risk, localized prostate cancer (PCa). J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.4764] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- S. J. Dibiase
- Cooper Health System, Camden, NJ; University of Maryland, Baltimore, MD
| | - N. Dawson
- Cooper Health System, Camden, NJ; University of Maryland, Baltimore, MD
| | - M. Naslund
- Cooper Health System, Camden, NJ; University of Maryland, Baltimore, MD
| | - A. Hussain
- Cooper Health System, Camden, NJ; University of Maryland, Baltimore, MD
| | - R. Kataria
- Cooper Health System, Camden, NJ; University of Maryland, Baltimore, MD
| | - M. Bangalore
- Cooper Health System, Camden, NJ; University of Maryland, Baltimore, MD
| | - A. Dhople
- Cooper Health System, Camden, NJ; University of Maryland, Baltimore, MD
| | - C. Guo
- Cooper Health System, Camden, NJ; University of Maryland, Baltimore, MD
| | - P. Amin
- Cooper Health System, Camden, NJ; University of Maryland, Baltimore, MD
| |
Collapse
|
34
|
Mannuel H, Dawson N, Guo C, Dorsey B, Besche M, Smoot J, Engstrom C, Hussain A. Phase I/II trial of weekly doxorubicin (Doxo)/docetaxel (Doce) followed by hormone ablation (HA) in recurrent prostate cancer (PC). J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.4765] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
| | - N. Dawson
- University of Maryland, Baltimore, MD
| | - C. Guo
- University of Maryland, Baltimore, MD
| | - B. Dorsey
- University of Maryland, Baltimore, MD
| | - M. Besche
- University of Maryland, Baltimore, MD
| | - J. Smoot
- University of Maryland, Baltimore, MD
| | | | | |
Collapse
|
35
|
Liu H, Hooper SB, Armugam A, Dawson N, Ferraro T, Jeyaseelan K, Thiel A, Koukoulas I, Wintour EM. Aquaporin gene expression and regulation in the ovine fetal lung. J Physiol 2003; 551:503-14. [PMID: 12819302 PMCID: PMC2343212 DOI: 10.1113/jphysiol.2003.044875] [Citation(s) in RCA: 43] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
Fetal lung development is dependent upon secretion of liquid into the future airways which must be cleared at birth to establish air-breathing. Aquaporins (AQP) 1, 3, 4 and 5 are membranous water channel proteins that are present in the lung after birth in rodents, with little expression before birth. Our aim was to describe the changes in AQP1, 3, 4 and 5 expression and protein levels in the fetal lung of a long-gestation species (sheep) and in response to physiological factors known to alter fetal lung liquid dynamics. Both mRNA and high protein levels were detected for AQP1, 3, 4 and 5 by day 100 (term is ~150 days in ovine fetuses). A cortisol infusion (120-131 days) significantly (P < 0.05) increased AQP1 (0.9 +/- 0.2 (n = 4) vs.1.8 +/- 0.3 (n = 5)) and AQP5 (8.8 +/- 0.6 vs. 14.1 +/- 1.2) mRNA levels in fetal lung (measured by real-time PCR). Ten days of tracheal obstruction significantly (P < 0.05) decreased AQP5 mRNA levels (6.1 +/- 0.9 (n = 5) vs. 2.7 +/- 0.3 (n = 5)). Immunohistochemistry was used to show that protein levels changed in parallel with the mRNA changes. These findings suggest that AQPs could be involved in lung liquid production and reabsorption during fetal development in long-gestation species.
Collapse
Affiliation(s)
- H Liu
- Department of Medical Genetics, Sun Yat Sen University, Guangzhou, PR China
| | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Meng F, Huang X, Zajdel R, Foster D, Dawson N, Lemanski S, Zawieja D, Dube D, Lemanski L. Erratum to “Relationship between cardiac protein tyrosine phosphorylation and myofibrillogenesis during axolotl heart development”. Tissue Cell 2003. [DOI: 10.1016/s0040-8166(03)00035-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
37
|
MacKay JM, Dawson N. Survey of Pediatrician and Family Physician Beliefs and Behavior Related to Providing Parent Education on Child Passenger Restraint Systems. Paediatr Child Health 2003. [DOI: 10.1093/pch/8.suppl_b.23b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
38
|
Meng F, Huang XP, Zhang C, Zajdel RW, Foster D, Dawson N, Lemanski SL, Zawieja D, Dube DK, Lemanski LF. Relationship between cardiac protein tyrosine phosphorylation and myofibrillogenesis during axolotl heart development. Tissue Cell 2003; 35:133-42. [PMID: 12747935 DOI: 10.1016/s0040-8166(03)00012-0] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
The axolotl, Ambystoma mexicanum, is a useful system for studying embryogenesis and cardiogenesis. To understand the role of protein tyrosine phosphorylation during heart development in normal and cardiac mutant axolotl embryonic hearts, we have investigated the state of protein tyrosine residues (phosphotyrosine, P-Tyr) and the relationship between P-Tyr and the development of organized sarcomeric myofibrils by using confocal microscopy, two-dimensional isoelectric focusing (IEF)/SDS-polyacrylamide gel electrophoresis (PAGE) and immunoblotting analyses. Western blot analyses of normal embryonic hearts indicate that several proteins were significantly tyrosine phosphorylated after the initial heartbeat stage (stage 35). Mutant hearts at stages 40-41 showed less tyrosine phosphorylated staining as compared to the normal group. Two-dimensional gel electrophoresis revealed that most of the proteins from mutant hearts had a lower content of phosphorylated amino acids. Confocal microscopy of stage 35 normal hearts using phosphotyrosine monoclonal antibodies demonstrated that P-Tyr staining gradually increased being localized primarily at cell-cell boundaries and cell-extracellular matrix boundaries. In contrast, mutant embryonic hearts showed a marked decrease in the level of P-Tyr staining, especially at sites of cell-cell and cell-matrix junctions. We also delivered an anti-phosphotyrosine antibody (PY 20) into normal hearts by using a liposome-mediated delivery method, which resulted in a disruption of the existing cardiac myofibrils and reduced heartbeat rates. Our results suggest that protein tyrosine phosphorylation is critical during myofibrillogenesis and embryonic heart development in axolotls.
Collapse
Affiliation(s)
- F Meng
- Medical Physiology, Texas A&M University System HSC, College Station, TX 77843, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Lynn J, Harrell FE, Cohn F, Hamel M, Dawson N, Wu AW. Defining the "terminally ill": insights from SUPPORT. Duquesne Law Rev 2002; 35:311-36. [PMID: 12385311] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/26/2023]
Affiliation(s)
- J Lynn
- The Center to Improve Care of the Dying, George Washington University, Washington, DC, USA
| | | | | | | | | | | |
Collapse
|
40
|
Hussain A, Dawson N, Amin P, Naslund M, Engstrom C, Chen T. Docetaxel followed by hormone therapy after failure of definitive treatments for clinically localized/locally advanced prostate cancer: preliminary results. Semin Oncol 2001; 28:22-31. [PMID: 11685725 DOI: 10.1016/s0093-7754(01)90151-4] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
An increasingly important issue in the management of prostate cancer is the occurrence of biochemical failure (ie, increasing serum prostate-specific antigen [PSA] levels) in patients with clinically localized prostate cancer who initially underwent definitive treatments with curative intent (prostatectomy and/or radiation therapy). This pilot trial evaluated chemotherapy followed by hormone therapy for a defined period in patients with biochemical (and possibly clinical) recurrence after initial local therapies for localized/locally advanced prostate cancer. Patients who developed increasing PSA > 4 ng/mL after initial prostatectomy and/or radiation therapy received docetaxel, 70 mg/m(2) every 3 weeks for up to 6 courses, followed by 4 months of total androgen suppression (using a luteinizing hormone-releasing hormone agonist plus bicalutamide, 50 mg/d) and 8 months of peripheral androgen blockade (using finasteride, 5 mg/d, plus bicalutamide, 50 mg/d). Twenty-seven patients have enrolled to date, 23 of whom received four or six cycles of docetaxel before hormonal therapies. Seventeen (74%) of 23 patients who completed four to six cycles of chemotherapy had a > or =40% decrease in PSA, and 16 (89%) of 18 patients who completed 4 months of total androgen suppression achieved PSA values of < or =0.1. The most common hematologic toxicity was grade (3/4) neutropenia; grade 3 nonhematologic toxicities were rare, and no grade 4 nonhematologic toxicities were reported. Thus, the preliminary results suggest that docetaxel before hormonal therapy includes a PSA response in many prostate cancer patients with biochemical failure after definitive local therapies.
Collapse
Affiliation(s)
- A Hussain
- Greenebaum Cancer Center, University of Maryland School of Medicine, and the Baltimore Veterans Affairs Medical Center, Department of Veterans Affairs, Baltimore, MD 21201, USA
| | | | | | | | | | | |
Collapse
|
41
|
Yuan Z, Dawson N, Cooper GS, Einstadter D, Cebul R, Rimm AA. Effects of alcohol-related disease on hip fracture and mortality: a retrospective cohort study of hospitalized Medicare beneficiaries. Am J Public Health 2001; 91:1089-93. [PMID: 11441736 PMCID: PMC1446699 DOI: 10.2105/ajph.91.7.1089] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
OBJECTIVES This study investigated the effect of alcohol-related disease on hip fracture and mortality. METHODS A retrospective cohort design was used. The study cohort consisted of hospitalized Medicare beneficiaries with alcohol-related disease (n = 150,119) and randomly matched controls without alcohol-related disease (n = 726,218) identified through the 1988-1989 inpatient claims file. Incidence rates of hip fracture and mortality were examined. RESULTS During the study period, 20,620 patients developed hip fracture, with 6973 cases among patients with alcohol-related disease and 13,647 cases among patients without alcohol-related disease. After adjustment for potential confounders, patients with alcohol-related disease had a 2.6-fold increased risk of hip fracture relative to patients without alcohol-related disease (95% confidence interval = 2.5, 2.6). Patients with alcohol-related disease had a higher risk of mortality at 1 year after hip fracture. CONCLUSIONS Alcohol-related disease increases the risk of hip fracture significantly and reduces long-term survival. The present results suggest that patients hospitalized for alcohol-related disease should be targeted for hip fracture prevention programs.
Collapse
Affiliation(s)
- Z Yuan
- Department of Epidemiology and Biostatistics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
| | | | | | | | | | | |
Collapse
|
42
|
Lemanski LF, Meng F, Lemanski SL, Dawson N, Zhang C, Foster D, Li Q, Nakatsugawa M, Zajdel RW, Dube DK, Huang X. Creation of chimeric mutant axolotls: a model to study early embryonic heart development in Mexican axolotls. Anat Embryol (Berl) 2001; 203:335-42. [PMID: 11411308 DOI: 10.1007/s004290100158] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The Mexican axolotl (Ambystoma mexicanum) provides an excellent model for studying heart development since it carries a cardiac lethal mutation in gene c that results in failure of contraction of mutant embryonic myocardium. In cardiac mutant axolotls (c/c) the hearts do not beat, apparently because of an absence of organized myofibrils. To date, there has been no way to analyze the genotypes of embryos from heterozygous spawnings (+/c x +/c) until stage 35 when the normal (+/c or +/+) embryos first begin to have beating hearts; mutant (c/c) embryos fail to develop normal heartbeats. In the present study, we created chimeric axolotls by using microsurgical techniques. The general approach was to transect tailbud embryos and join the anterior and posterior halves of two different individuals. The chimeric axolotl is composed of a normal head and heart region (+/+), permitting survival and a mutant body containing mutant gonads (c/c) that permits the production of c/c mutant offspring: 100% c/c offspring were obtained by mating c/c chimeras (c/c x c/c). The mutant phenotypes were confirmed by the absence of beating hearts and death at stage 41 in 100% of the embryos. Examination of the mutant hearts with electron microscopy and comfocal microscopy after immunofluorescent staining for tropomyosin showed identical images to those described previously in naturally-occurring c/c mutant axolotls (i.e., lacking organized sarcomeric myofibrils). These "c/c chimeric" axolotls provide a useful and unique way to investigate early embryonic heart development in cardiac mutant Mexican axolotls.
Collapse
Affiliation(s)
- L F Lemanski
- Department of Medical Physiology, TX A&M University System Health Science Center, 108 Reynolds Medical Building, College Station, Texas 77843, USA.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|
43
|
Jhund PS, Dawson N, Davie AP, Sattar N, Norrie J, O'Kane KP, McMurray JJ. Attenuation of endothelin-1 induced vasoconstriction by 17beta estradiol is not sustained during long-term therapy in postmenopausal women with coronary heart disease. J Am Coll Cardiol 2001; 37:1367-73. [PMID: 11300448 DOI: 10.1016/s0735-1097(01)01168-8] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
Abstract
OBJECTIVES The goal of this study was to determine the long-term effects of estrogen replacement therapy on the response to endothelin-1 (ET-1) in postmenopausal women with coronary heart disease. BACKGROUND It is thought that the vasoconstrictor ET-1 is involved in the development and progression of atherosclerosis. Estrogen replacement may slow the development of atherosclerosis in postmenopausal women. METHODS Nineteen of 20 postmenopausal women randomized to either three months of 2 mg oral estradiol or placebo completed the double-blind placebo-controlled protocol. Change in forearm blood flow (FBF) in response to a 60 min brachial arterial infusion of ET-1 (5 pmol/min) was measured before randomization, after one month of randomized therapy and after three months of therapy using venous occlusion plethysmography. RESULTS Estrogen treatment had no effect on baseline FBF. Systolic and diastolic blood pressure and heart rate did not change in response to estrogen therapy or ET-1. Before randomization, in response to ET-1, FBF was reduced by -21.9% (mean response over 60 min) in the placebo group and -19.0% in the estradiol group (p = 0.67). After one month of therapy, the response was attenuated in the estrogen group, -10.0%, compared with the placebo group, -23.6 (difference in means 13.6%, 95% confidence interval [0.7%, 26.6%], p = 0.041). After three months of therapy, there was no difference in response between the placebo group, -27.0%, and estrogen group, -30.2% (p = 0.65). CONCLUSIONS In postmenopausal women with coronary heart disease, estrogen therapy inhibits the vasoconstrictor response to ET-1 after one month of therapy. This effect is lost after three months of therapy, suggesting that tachyphylaxis to one potentially beneficial action of estradiol develops during chronic treatment.
Collapse
Affiliation(s)
- P S Jhund
- Department of Cardiology, Western Infirmary, Glasgow, Scotland
| | | | | | | | | | | | | |
Collapse
|
44
|
Hussain A, Dawson N. Management of advanced/metastatic prostate cancer: 2000 update. Oncology (Williston Park) 2000; 14:1677-88; discussion 1688, 1691-4. [PMID: 11204373] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/19/2023]
Abstract
Over the past several years, the clinical presentation of prostate cancer has evolved so that more patients than ever before are presenting with clinically localized disease. However, a significant number of men continue to present with locally advanced or metastatic prostate cancer, or go on to develop metastasis after failing local therapies. Despite our better understanding of the biological principles and newer therapies, metastatic prostate cancer remains a lethal disease. Androgen ablation continues to be the first, most effective line of treatment for advanced/metastatic prostate cancer. Newer chemotherapy combinations with increasing activity are being identified in hormone-resistant prostate cancer. Based on novel targets, new treatment strategies are being developed and incorporated into clinical trials. Ultimately, the impact of these evolving treatments on advanced/hormone-resistant prostate cancer can best be assessed by well-designed phase III trials, many of which are now being launched or awaiting completion.
Collapse
Affiliation(s)
- A Hussain
- Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, USA
| | | |
Collapse
|
45
|
Abstract
Opioids administered to peripheral tissues can have significant analgesic effects in doses which would not be effective centrally. We have assessed the effects of regional diamorphine 2.5 mg i.v. in 14 patients undergoing surgical correction of bilateral arthritic foot deformities in a prospective, randomized, double-blind study. Patients acted as their own controls as only one foot received the active drug. Visual analogue scale (VAS) pain scores and wound tenderness were measured over 72 h. Diamorphine did not improve median VAS area under the curve pain scores during the first 6 h after surgery (33 (95% confidence intervals (CI) 25-46) vs 24 (17-35)). It also did not effect wound hypersensitivity when tested at 72 h after surgery (95 (47-125) vs 90 (50-125) g). There were no significant adverse effects.
Collapse
Affiliation(s)
- M G Serpell
- Department of Anaesthesia, Western Infirmary, Glasgow, UK
| | | | | | | |
Collapse
|
46
|
Johnston H, Koukoulas I, Jeyaseelan K, Armugam A, Earnest L, Baird R, Dawson N, Ferraro T, Wintour EM. Ontogeny of aquaporins 1 and 3 in ovine placenta and fetal membranes. Placenta 2000; 21:88-99. [PMID: 10692256 DOI: 10.1053/plac.1999.0445] [Citation(s) in RCA: 62] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
A sensitive and highly reproducible method has been used to show that Aquaporin 3 (AQP(3)) mRNA is present in the ovine placenta and chorion from at least 60 days of gestation (term=145-150d) with levels increasing substantially (>16 fold) at 100 days, and remaining constant thereafter. By immuno- and hybridization histochemistry, the epithelial cells expressing AQP(3)were found to be the trophoblast cells. Some AQP(3)was expressed in fibroblasts of the amnion and allantois but none was expressed in the epithelia of these membranes. AQP(1)was expressed in endothelial cells of fetal and maternal blood vessels but not in any epithelial cell of the ovine placenta and fetal membranes. The level of AQP(3)expression is consistent with known ovine placental permeabilities to water, glycerol and urea.
Collapse
Affiliation(s)
- H Johnston
- Howard Florey Institute of Experimental Physiology and Medicine, University of Melbourne, Parkville, 3052, Australia
| | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Bubley GJ, Carducci M, Dahut W, Dawson N, Daliani D, Eisenberger M, Figg WD, Freidlin B, Halabi S, Hudes G, Hussain M, Kaplan R, Myers C, Oh W, Petrylak DP, Reed E, Roth B, Sartor O, Scher H, Simons J, Sinibaldi V, Small EJ, Smith MR, Trump DL, Wilding G. Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol 1999; 17:3461-7. [PMID: 10550143 DOI: 10.1200/jco.1999.17.11.3461] [Citation(s) in RCA: 774] [Impact Index Per Article: 31.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
PURPOSE Prostate-specific antigen (PSA) is a glycoprotein that is found almost exclusively in normal and neoplastic prostate cells. For patients with metastatic disease, changes in PSA will often antedate changes in bone scan. Furthermore, many but not all investigators have observed an association between a decline in PSA levels of 50% or greater and survival. Since the majority of phase II clinical trials for patients with androgen-independent prostate cancer (AIPC) have used PSA as a marker, we believed it was important for investigators to agree on definitions and values for a minimum set of parameters for eligibility and PSA declines and to develop a common approach to outcome analysis and reporting. We held a consensus conference with 26 leading investigators in the field of AIPC to define these parameters. RESULT We defined four patient groups: (1) progressive measurable disease, (2) progressive bone metastasis, (3) stable metastases and a rising PSA, and (4) rising PSA and no other evidence of metastatic disease. The purpose of determining the number of patients whose PSA level drops in a phase II trial of AIPC is to guide the selection of agents for further testing and phase III trials. We propose that investigators report at a minimum a PSA decline of at least 50% and this must be confirmed by a second PSA value 4 or more weeks later. Patients may not demonstrate clinical or radiographic evidence of disease progression during this time period. Some investigators may want to report additional measures of PSA changes (ie, 75% decline, 90% decline). Response duration and the time to PSA progression may also be important clinical end point. CONCLUSION Through this consensus conference, we believe we have developed practical guidelines for using PSA as a measurement of outcome. Furthermore, the use of common standards is important as we determine which agents should progress to randomized trials which will use survival as an end point.
Collapse
Affiliation(s)
- G J Bubley
- Beth Israel Deaconess Medical Center, Dana Farber Cancer Center, and Massachusetts General Hospital, Boston, MA, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Jonah B, Yuen L, Au-Yeung E, Paterson D, Dawson N, Thiessen R, Arora H. Front-line police officers' practices, perceptions and attitudes about the enforcement of impaired driving laws in Canada. Accid Anal Prev 1999; 31:421-443. [PMID: 10440540 DOI: 10.1016/s0001-4575(98)00081-5] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
A survey of front line police officers' practices, perceptions and attitudes regarding detection of impaired driving, processing of driving while impaired (DWI) charges, criminal court proceedings and DWI sanctions was conducted across Canada. A sample of 1545 officers of all jurisdictions across the country, representative of different types of police services (i.e. national, provincial, municipal) and types of policing (i.e. traffic, general duty) were surveyed by mail. The results, based on a 71% response rate, indicate that: an average of 7.5 charges/year are laid by officers resulting mainly from erratic driving; videotaping and mobile breath testing could improve efficiency of DWI enforcement; it takes an average of 2 h 48 min to process each DWI charge; about 2/3 of officers say plea bargaining occurs at least sometimes; the average length of DWI trial is over 4 h; less than half of officers think Crown Attorneys are adequately prepared for DWI cases; about 3/4 of officers think the accused escapes conviction on a legal technicality at least sometimes; about 30% of officers say short-term licence suspensions and other forms of discretion are used at least sometimes; DWI places fifth in priority among 15 offences, up from eighth in a 1981 survey; DWI is a priority for most police management but human resources are not adequate; and there is greater support for administrative than for Criminal Code changes. Multiple regressions indicated that the number of DWI charges laid by officers depended mainly on the officers' personal priority regarding DWI enforcement. The results suggest that many officers want to enforce DWI laws but that the numerous procedural and legal barriers that they confront often force them to exercise discretion in the laying of DWI charges.
Collapse
Affiliation(s)
- B Jonah
- Road Safety Directorate, Transport Canada, Place de Ville, Ottawa, Ont., Canada.
| | | | | | | | | | | | | |
Collapse
|
49
|
Dawson N, Figg WD, Brawley OW, Bergan R, Cooper MR, Senderowicz A, Headlee D, Steinberg SM, Sutherland M, Patronas N, Sausville E, Linehan WM, Reed E, Sartor O. Phase II study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal. Clin Cancer Res 1998; 4:37-44. [PMID: 9516950] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
Management of prostate cancer progression after failure of initial hormonal therapy is controversial. Recently, the activity of the simple discontinuation of antiandrogen therapy has been established by several groups, as well as the enhanced activity when combined with adrenal suppression (i.e., aminoglutethimide and hydrocortisone). Furthermore, suramin has generated considerable interest following reports of response rates ranging from 17 to 70%. More recently, suramin response rates of 18 and 22% have been reported when the potential confounding variables of flutamide withdrawal and hydrocortisone were prospectively controlled. On the basis of the activity of combining aminoglutethimide with flutamide withdrawal, we designed a protocol in which suramin was combined with aminoglutethimide in two cohorts of patients (those with simultaneous antiandrogen withdrawal compared to those who had previously discontinued antiandrogen therapy). Eighty-one evaluable patients were enrolled in this study between June 1992 and November 1994. Patients were a priori divided into two cohorts, those receiving prior antiandrogen withdrawal (n = 56) and those receiving simultaneous antiandrogen withdrawal (n = 25) at the time the patients were enrolled into the trial. For the group that discontinued antiandrogen prior to enrolling in therapy, the partial response rate (> 50% decline in PSA for > 4 weeks) was 14.2%, whereas the partial response was 44% for those patients who discontinued their antiandrogen at the time of starting suramin and aminoglutethimide. The median time to progression was 3.9 months in patients failing prior antiandrogen withdrawal and 5.5 months in those patients having concomitant antiandrogen withdrawal (P = 0.36 for the overall difference). The progression-free survival estimate at 1 year for patients having prior antiandrogen withdrawal was 19.8% [95% confidence interval (CI), 11-32.9%]. For those patients who experienced antiandrogen withdrawal simultaneous with the treatment, the progression-free survival estimates at 1 and 2 years were 27.1 (95% CI, 13.2-47.6%) and 4.5% (95% CI, 0.8-21.6%). The median survival time for those patients having prior antiandrogen withdrawal was 14.2 months, whereas the median survival was 21.9 months for those having concomitant antiandrogen withdrawal (P = 0.029 for the overall difference). In conclusion, the partial response rate of 44% for those who had concomitant flutamide withdrawal with adrenal suppression was consistent with that of other reports using a similar maneuver. Although this study was not randomized and thus we should not over-interpret the results, flutamide withdrawal plus adrenal suppression appears to have greater activity than flutamide withdrawal alone. Furthermore, these data suggest that suramin adds little to the response rate observed for other adrenal suppressive agents in the presence of antiandrogen withdrawal. This interpretation is in agreement with those studies controlling for adrenal suppression and flutamide withdrawal prior to suramin administration, which noted modest activity of short duration. Given that antiandrogen withdrawal is now accepted as an active maneuver for a subset of patients progressing after maximum androgen blockade, we propose that future trials attempting to maximize response rates incorporate this maneuver whenever possible into prospectively designed regimens.
Collapse
Affiliation(s)
- N Dawson
- Clinical Pharmacology Branch, National Cancer Institute, NIH, Bethesda, Maryland 20892, USA
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
50
|
Kenner JR, Sperling LC, Waselenko J, Dawson N, Sau P, Moul JW. Suramin keratosis: a unique skin eruption in a patient receiving suramin for metastatic prostate cancer. J Urol 1997; 158:2245-6. [PMID: 9366363 DOI: 10.1016/s0022-5347(01)68218-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- J R Kenner
- Dermatology Services, Walter Reed Army Medical Center, Washington, D.C. 20307-5001, USA
| | | | | | | | | | | |
Collapse
|